Evidence map›Paper›PMID 12466785›Full record

Trial reportJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology

Carvedilol improves left ventricular function in heart failure patients with idiopathic dilated cardiomyopathy and a wide range of sympathetic nervous system function as measured by iodine 123 metaiodobenzylguanidine.

Myron C Gerson, Laura L Craft, Nancy McGuire, Damodhar P Suresh, William T Abraham, Lynne E Wagoner

Registry-linked trialAbstract readClinical Trial
PubMed Publisher
In one paragraph

Trial report in Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03227393 (The Effect of Yoga on Cardiac Sympathetic Innervation Evaluated by I-123 mIBG), which is not on this map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03227393 nawithdrawnnot on this map

The Effect of Yoga on Cardiac Sympathetic Innervation Evaluated by I-123 mIBG

TypeinterventionalSponsorUniversity of CincinnatiRan2017 to 2017Enrolled0ConditionsHeart Failure, SystolicArmsYoga training
3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 91 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Normal values and within-subject variability of cardiac I-123 MIBG scintigraphy in healthy individuals: implications for clinical studies.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
    Trial
  5. Cardiac sympathetic activity pre and post resynchronization therapy evaluated by 123I-MIBG myocardial scintigraphy.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
    Trial
  6. Review
  7. Review
  8. Observational
  9. Review
  10. Heart rate response to vasodilator stress: A potential new application for a proven prognostic parameter.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021
    Article
  11. Assessment of right ventricular sympathetic dysfunction in patients with arrhythmogenic right ventricular cardiomyopathy: AnJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2020
    Article
  12. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2019
    Article
  13. How do we establish cardiac sympathetic nervous system imaging withJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2019
    Article
  14. Review
  15. Cardiac neuroanatomy - Imaging nerves to define functional control.Autonomic neuroscience : basic & clinical · 2017
    Review
  16. Cardiac molecular imaging to track left ventricular remodeling in heart failure.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2017
    Review
  17. Article
  18. ASNC imaging guidelines for SPECT nuclear cardiology procedures: Stress, protocols, and tracers.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2016
    Article
  19. I-123 MIBG Cardiac Imaging.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2015
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Myron C GersonDivision of Cardiology, Department of Internal Medicine, University of Cincinnati Medical Center, Cincinnati, Ohio 45267, USA. myron.gerson@uc.edu
Laura L Craft
Nancy McGuire
Damodhar P Suresh
William T Abraham
Lynne E Wagoner
University of Cincinnati · USUniversity of Cincinnati Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCarvedilol treatment reduces the mortality rate in patients with congestive heart failure. It is not known whether carvedilol treatment is effective in heart failure patients with substantial cardiac sympathetic nerve dysfunction. The goal of this study was to determine the effect of chronic carvedilol treatment in patients with cardiac sympathetic nerve dysfunction of varying severity. METHODS AND

resultsIn 22 congestive heart failure patients with idiopathic cardiomyopathy, sympathetic nerve function was assessed before and after 7.2 +/- 2.7 months of carvedilol treatment with the use of iodine 123 metaiodobenzylguanidine (MIBG) imaging, radionuclide ventriculography, and transmyocardial norepinephrine sampling. Patients with relatively advanced impairment of cardiac sympathetic nerve function, as manifested by a baseline I-123 MIBG ratio lower than 1.40, had a statistically significant improvement in I-123 heart-mediastinum ratio with carvedilol treatment, from 1.26 +/- 0.12 to 1.39 +/- 0.20 (P =.004). Of 10 patients with a baseline I-123 MIBG ratio lower than 1.40, 9 had an increase in the heart-mediastinum ratio with carvedilol treatment. Left ventricular ejection fraction increased from 25.4% +/- 7.8% to 37.3% +/- 14.7% (P <.001), with no difference between patients with relatively advanced versus relatively preserved cardiac sympathetic nerve function.

conclusionMost patients with congestive heart failure show a favorable response in left ventricular function to carvedilol treatment, regardless of the baseline level of cardiac sympathetic nervous system function, as assessed by neuronal imaging with I-123 MIBG. Patients with relatively advanced impairment of baseline I-123 MIBG uptake are most likely to show evidence of improved cardiac sympathetic nervous system function in response to carvedilol therapy.

Indexed as

3-IodobenzylguanidineAdrenergic beta-AntagonistsAgedCarbazolesCardiomyopathy, DilatedCarvedilolFemaleHeart FailureHeart VentriclesHumansMaleMiddle AgedNorepinephrinePropanolaminesRadionuclide ImagingRadiopharmaceuticals3-IodobenzylguanidineAdrenergic beta-AntagonistsCarbazolesCarvedilolNorepinephrinePropanolaminesRadiopharmaceuticals

Identifiers

PMID12466785
OpenAlexW2088682938

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.